|
||||||||||||||||
|
||||||||||||||||
The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Canadian Gulf War Veterans Study, 44, 58 diseases of the digestive system, 158, 166 mental and behavioral disorders, 105 chronic fatigue syndrome, 213 Cancer all cancers, 8, 74-75, 80-82, 257 brain cancer, 2, 9, 10, 20, 73-74, 75, 76, 78, 79, 125, 231, 261 derivative studies, 42, 44, 52 digestive tract, 76 hospitalization studies, 73, 74, 75-76, 80, 81 latency, 8, 28, 41, 73, 74, 78 leukemias and lymphomas, 73 mortality studies, 73, 74-75, 76, 78, 79, 80, 81, 82, 125, 226-227 nerve agent exposure and, 73-74, 75, 77, 78, 79 oil-well fire smoke and, 74, 75, 78 pesticide exposure and, 78 primary studies, 75-76, 79-82, 125 recommendation, 78 registry data, 9 research recommendations, 9, 10 testicular, 2, 4, 15, 19, 73, 74, 76, 78, 79-80, 81, 208 updated and supplemental literature, 75-78 vaccines/vaccination and, 77 Volume 4 summary, 4, 19, 20, 73-75 Cardiac dysrhythmia, 135, 140, 141 Cardiovascular disease. See Circulatory system diseases Cause-specific mortality. See External causes of mortality Centers for Disease Control and Prevention (CDC), 47, 49, 52, 59, 116, 200, 205, 208, 210, 211, 212, 213, 219, 220, 256, 270 Central nervous system (CNS), 160, 267, 270, 275, 276, 278, 279 Chalder Fatigue Scale, 213 Chemical agent exposure, and neurological diseases, 47, 59-60, 121, 133 Chemical and biologic warfare threat of, 14-15, 55, 212, 213 Chlorinated hydrocarbons, 14 Cholinesterase inhibitors. See also Pesticide/insecticide exposures; Pyridostigmine bromide exposures during Gulf War, 266-270 genetic susceptibility, 61, 276-278 illnesses associated with, 60, 267-268 long-term effects of low doses, 270 multisymptom illnesses, 57, 61, 62, 278-279 studies in Gulf War populations, 60, 271-274 Chronic dysphoria, 105 Chronic fatigue syndrome (CFS), 7. See also Multisymptom illnesses chemical sensitivity and, 45 in disabled veterans, 52, 214, 220 identification of predictors, 42 mental and behavioral disorders and, 102 multisymptom illnesses, 60, 207, 211 oil-fire smoke exposure and, 214 pesticide exposure and, 52, 55, 213, 214 prevalence, 46, 47, 53, 55, 60, 61, 213, 214 primary studies, 211-212, 219-220 pyridostigmine bromide and, 55, 213, 214 threat of chemical weapons and, 55, 212, 213 updated and supplemental literature, 213-214, 220 Chronic multisymptom illness (CMI). See Multisymptom illnesses Chronic obstructive pulmonary disease, 145, 148, 150 Chronic widespread pain (CWP). See also Fibromyalgia alcohol use and, 177 cognitive performance, 50, 118 combat exposure and, 50, 177, 178 comorbid with mental disorders, 102 delayed-onset, 177 identification of predictors of, 42, 50 pesticide exposure and, 178 pyridostigmine bromide exposure and, 178 musculoskeletal, 1, 3, 10, 18, 19, 47, 57, 118, 120 primary studies, 176-177, 178, 179 self-reports of, 18, 42, 43, 57 stress perceptions and, 177, 178 Volume 4 summary, 3 Circulatory system diseases. See also specific diseases and conditions female veterans, 138 hospitalization studies, 135, 136, 137, 140, 141, 142, 218 latency, 28
|
|
|||||||||||||||
